by Animal biotechnology is the broad range of technologies that use living systems, organisms, or derivatives thereof to make or modify animal products for various benefits and uses. Some of the key technologies used in animal biotechnology include genetic engineering, cloning, gene therapy, embryo transfer and in vitro fertilization, gamete collection and storage, and embryo manipulation and storage. These technologies aim to improve animal health, increase production efficiency, and develop new pharmaceutical and medical products. However, some of these techniques are also highly controversial due to ethical and environmental concerns.
Genetic Engineering of Livestock
One of the major applications of Animal Biotechnology is the genetic engineering of livestock for improved production traits. Livestock like cows, goats, pigs, sheep, and poultry are genetically modified to express desired traits like increased milk production, larger litter sizes, more muscle growth, higher disease resistance, etc. For example, cows have been engineered to express higher versions of bovine growth hormone to increase their milk yields. Pigs have been given genes to alter their fat content to make leaner meat. While these modifications aim to boost global food supplies, critics argue that they prioritize corporate profits over animal welfare. There are also concerns about the unintended impacts of gene escape on natural populations and ecosystems.
Cloning of Livestock
Cloning allows for the mass production of genetically identical copies of superior livestock. The cloning of Dolly the sheep in 1996 demonstrated that mammals could be cloned from adult differentiated cells. Since then, cattle, pigs, goats, horses and other farm animals are routinely cloned commercially using somatic cell nuclear transfer. Cloned livestock is seen as a way to rapidly multiply elite genetics for desirable traits. However, the process of cloning is still inefficient, costly, and causes significant suffering to animals. It also blurs natural boundaries by allowing one animal’s genetics to be endlessly propagated. Opponents argue that cloning prioritizes commercial production over an animal’s natural life experience and ability to express its genetic variation.
Use of Animals in Biomedical Research
Animal models remain crucial in developing therapies and vaccines for human diseases. Mice, rats, rabbits, pigs and other species are genetically engineered or naturally carry diseases closely resembling human conditions like cancer, diabetes, Alzheimer’s, influenza etc. Researchers conduct tests on these animals to understand disease mechanisms, screen drug candidates, and develop new medical procedures and devices. Promising outcomes in animal trials are then tested on human volunteers. While this research has led to many medical advances, some activists object to using and harming sentient animals against their will for human benefits. Others argue that some research inflicts unnecessary pain or that alternatives like computer models should be given more priority. Proponents counter that stringent regulations ensure research causes minimal distress to animals.
Gene Drives and Biotech Approaches to Control Invasive Species
Novel biotechnology tools are being developed to control invasive species threatening biodiversity. One such approach is gene drives, which aim to bias inheritance to spread desired genes throughout a population. For example, researchers have developed gene drives that could suppress populations of invasive rodents destroying habitats in island ecosystems. Scientists argue this biotech tool could help restore balance without pesticides. However, others caution that gene drives pose difficult-to-predict environmental risks by intentionally spreading engineered genes. There are also concerns that the same technique could potentially be misused for bioweapons. While control of invasive species is essential, developing and releasing self-sustaining gene drives requires extensive risk assessment and governance to protect biodiversity and biosecurity.
Developing Better Farming with Animal Biotechnology
Another application of animal biotechnology is to develop new traits in livestock and aquaculture species to support more sustainable, climate-resilient and compassionate food production systems. Technologies to enhance animal welfare, reduce greenhouse gas emissions, utilize novel feed sources and improve disease resistance could help shift industrial animal agriculture towards regenerative models. For example, cattle and pigs could be modified to prosper on feedstocks like food waste, grazing lands or seaweed instead of resource-intensive grain. Aquacultured species like salmon could be selectively bred for traits that reduce dependence on wild fish as feed. However, critics point out that a more ethical path forward relies less on novel technologies and more on agro-ecological solutions that prioritize small farms, improve standards of care and revive traditional grazing practices.
Benefits for Human Healthcare
Animal biotechnology also has promising applications for developing life-saving medicines and therapies. Pharmaceutical proteins and therapeutics can be cost-effectively produced at scale by engineering the milk of goats, cattle or other livestock species. Monoclonal antibodies, clotting factors and other medical products are already commercially manufactured this way. Pigs, goats and primates are being genetically engineered to serve as living bioreactors, growing transplantable human organs to address shortage crises. Cell and gene therapies tested in animal models also offer hope for conditions like muscular dystrophy, Parkinson’s disease and various cancers. For many patients, such advances enabled by animal research mean the difference between a cure and lifelong dependency. However, critics argue the welfare costs to animals are often downplayed and that relying less on animal models could speed translation to human clinical trials.
while animal biotechnology has potential benefits, its application also raises complex societal, ethical and ecological issues. Advocates argue that continued innovation is necessary to address pressing global problems of health, hunger and sustainability. However, critics point to risks of unintended consequences and argue that alternatives relying less on novel technologies should first be exhausted. As the field evolves, balancing benefits, costs and risk mitigation through open public dialogue and stringent regulation will remain crucial. Future trajectories will depend a great deal on how well governance mechanisms uphold principles of responsible research, transparency and protection of biodiversity, farming communities and animal welfare.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
About Author - Vaagisha Singh
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. LinkedIn
